JP2022540353A5 - - Google Patents

Info

Publication number
JP2022540353A5
JP2022540353A5 JP2021577587A JP2021577587A JP2022540353A5 JP 2022540353 A5 JP2022540353 A5 JP 2022540353A5 JP 2021577587 A JP2021577587 A JP 2021577587A JP 2021577587 A JP2021577587 A JP 2021577587A JP 2022540353 A5 JP2022540353 A5 JP 2022540353A5
Authority
JP
Japan
Application number
JP2021577587A
Other languages
Japanese (ja)
Other versions
JPWO2020259584A5 (https=
JP2022540353A (ja
JP7560136B2 (ja
Filing date
Publication date
Priority claimed from CN201910572091.9A external-priority patent/CN112142743A/zh
Application filed filed Critical
Publication of JP2022540353A publication Critical patent/JP2022540353A/ja
Publication of JPWO2020259584A5 publication Critical patent/JPWO2020259584A5/ja
Publication of JP2022540353A5 publication Critical patent/JP2022540353A5/ja
Application granted granted Critical
Publication of JP7560136B2 publication Critical patent/JP7560136B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021577587A 2019-06-28 2020-06-24 チロシンキナーゼ2活性を仲介する複素環式化合物 Active JP7560136B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201910572091.9 2019-06-28
CN201910572091.9A CN112142743A (zh) 2019-06-28 2019-06-28 杂环类化合物、其制备方法及其在医药学上的应用
PCT/CN2020/098105 WO2020259584A1 (en) 2019-06-28 2020-06-24 Heterocyclic compounds for mediating tyrosine kinase 2 activity

Publications (4)

Publication Number Publication Date
JP2022540353A JP2022540353A (ja) 2022-09-15
JPWO2020259584A5 JPWO2020259584A5 (https=) 2023-06-02
JP2022540353A5 true JP2022540353A5 (https=) 2023-06-02
JP7560136B2 JP7560136B2 (ja) 2024-10-02

Family

ID=73869063

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021577587A Active JP7560136B2 (ja) 2019-06-28 2020-06-24 チロシンキナーゼ2活性を仲介する複素環式化合物

Country Status (12)

Country Link
US (1) US12448382B2 (https=)
EP (1) EP3990449A4 (https=)
JP (1) JP7560136B2 (https=)
KR (1) KR102926602B1 (https=)
CN (2) CN112142743A (https=)
AU (1) AU2020301437B2 (https=)
BR (1) BR112021026531A2 (https=)
CA (1) CA3144799A1 (https=)
MX (1) MX2021015969A (https=)
PH (1) PH12021553257A1 (https=)
TW (1) TWI851747B (https=)
WO (1) WO2020259584A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112142743A (zh) * 2019-06-28 2020-12-29 广州诺诚健华医药科技有限公司 杂环类化合物、其制备方法及其在医药学上的应用
TWI782599B (zh) * 2020-07-02 2022-11-01 美商輝瑞股份有限公司 胺基嘧啶基衍生物
CN113234081A (zh) * 2021-05-27 2021-08-10 东南大学 一种吡咯并吡唑衍生物与dmpeda做脲的制备方法
JP2024539280A (ja) 2021-10-25 2024-10-28 カイメラ セラピューティクス, インコーポレイテッド Tyk2分解剤およびそれらの使用
WO2025124465A1 (en) * 2023-12-15 2025-06-19 Beijing Innocare Pharma Tech Co., Ltd. Method for treating atopic dermatitis

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2011328237A1 (en) * 2010-11-09 2013-05-23 Cellzome Limited Pyridine compounds and aza analogues thereof as TYK2 inhibitors
US9586962B2 (en) * 2011-04-20 2017-03-07 Janssen Pharmaceutica Nv Disubstituted octahydropyrrolo [3,4-C] pyrroles as orexin receptor modulators
EP2832734A4 (en) * 2012-03-28 2015-08-26 Takeda Pharmaceutical HETEROCYCLIC COMPOUND
CN105622638B (zh) * 2014-10-29 2018-10-02 广州必贝特医药技术有限公司 嘧啶或吡啶并吡啶酮类化合物及其制备方法和应用
CN108137559B (zh) 2015-07-09 2021-11-02 默克专利有限公司 用作btk抑制剂的嘧啶衍生物及其用途
US11649251B2 (en) * 2017-09-20 2023-05-16 Kura Oncology, Inc. Substituted inhibitors of menin-MLL and methods of use
CN112142743A (zh) * 2019-06-28 2020-12-29 广州诺诚健华医药科技有限公司 杂环类化合物、其制备方法及其在医药学上的应用

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021015500A2 (https=)
BR102021007058A2 (https=)
BR102020022030A2 (https=)
BR112023016292A2 (https=)
BR112023011610A2 (https=)
BR112023011539A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)
BR102021016551A2 (https=)